Cargando…

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy

OBJECTIVES: This study was initiated to establish a renal thrombotic microangiopathy (TMA) scoring system based on clinical needs and investigate its predictive value for patients’ long-term outcomes. METHODS: Kidney biopsy-proven Complement-mediated TMA (C-TMA) patients from January 2000 to Decembe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fei-Fei, Yu, Xiao-Juan, Wang, Hui, Zhang, Xu, Tan, Ying, Qu, Zhen, Wang, Su-Xia, Yu, Feng, Chen, Min, Zhao, Ming-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848373/
https://www.ncbi.nlm.nih.gov/pubmed/36648027
http://dx.doi.org/10.1080/0886022X.2022.2161396
_version_ 1784871695193997312
author Chen, Fei-Fei
Yu, Xiao-Juan
Wang, Hui
Zhang, Xu
Tan, Ying
Qu, Zhen
Wang, Su-Xia
Yu, Feng
Chen, Min
Zhao, Ming-Hui
author_facet Chen, Fei-Fei
Yu, Xiao-Juan
Wang, Hui
Zhang, Xu
Tan, Ying
Qu, Zhen
Wang, Su-Xia
Yu, Feng
Chen, Min
Zhao, Ming-Hui
author_sort Chen, Fei-Fei
collection PubMed
description OBJECTIVES: This study was initiated to establish a renal thrombotic microangiopathy (TMA) scoring system based on clinical needs and investigate its predictive value for patients’ long-term outcomes. METHODS: Kidney biopsy-proven Complement-mediated TMA (C-TMA) patients from January 2000 to December 2017 in Peking University First Hospital were retrospectively studied. Both acute and chronic TMA-related lesions, including 15 pathologic indices, were semiquantitatively scored. The interobserver and intraobserver reproducibility and correlation between the pathologic indices and clinical parameters were analyzed. Furthermore, the patients were divided into 2 groups by dialysis use at baseline, and the association of these pathologic indices with their prognostic outcomes was assessed between the two groups. RESULTS: Ninety-two patients with renal biopsy-proven C-TMA were enrolled. All fifteen included pathology indices showed good or moderate interobserver and intraobserver reproducibility and correlated well with several clinical parameters. Several clinicopathological indices were worse in the dialysis group than in the nondialysis group, such as serum creatinine, hemoglobin, platelet count, and estimated glomerular filtration rate. Moreover, morphologic features in the dialysis group presented with more severe vascular lesions. Interstitial fibrosis and chronic tubulointerstitial lesions were related to a trend of high risk of continuous dialysis in the dialysis group. Based on univariate and multivariable Cox regression analysis, more severe glomerular lesions, including glomerular mesangiolysis, glomerular basement membrane double contours and glomerular mesangial proliferation, were identified as risk factors predicting worse prognosis. CONCLUSIONS: Our renal C-TMA semiquantitative scoring system is reliable with good reproducibility and prognostic value in clinical practice, which needs further validation.
format Online
Article
Text
id pubmed-9848373
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-98483732023-01-19 Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy Chen, Fei-Fei Yu, Xiao-Juan Wang, Hui Zhang, Xu Tan, Ying Qu, Zhen Wang, Su-Xia Yu, Feng Chen, Min Zhao, Ming-Hui Ren Fail Clinical Study OBJECTIVES: This study was initiated to establish a renal thrombotic microangiopathy (TMA) scoring system based on clinical needs and investigate its predictive value for patients’ long-term outcomes. METHODS: Kidney biopsy-proven Complement-mediated TMA (C-TMA) patients from January 2000 to December 2017 in Peking University First Hospital were retrospectively studied. Both acute and chronic TMA-related lesions, including 15 pathologic indices, were semiquantitatively scored. The interobserver and intraobserver reproducibility and correlation between the pathologic indices and clinical parameters were analyzed. Furthermore, the patients were divided into 2 groups by dialysis use at baseline, and the association of these pathologic indices with their prognostic outcomes was assessed between the two groups. RESULTS: Ninety-two patients with renal biopsy-proven C-TMA were enrolled. All fifteen included pathology indices showed good or moderate interobserver and intraobserver reproducibility and correlated well with several clinical parameters. Several clinicopathological indices were worse in the dialysis group than in the nondialysis group, such as serum creatinine, hemoglobin, platelet count, and estimated glomerular filtration rate. Moreover, morphologic features in the dialysis group presented with more severe vascular lesions. Interstitial fibrosis and chronic tubulointerstitial lesions were related to a trend of high risk of continuous dialysis in the dialysis group. Based on univariate and multivariable Cox regression analysis, more severe glomerular lesions, including glomerular mesangiolysis, glomerular basement membrane double contours and glomerular mesangial proliferation, were identified as risk factors predicting worse prognosis. CONCLUSIONS: Our renal C-TMA semiquantitative scoring system is reliable with good reproducibility and prognostic value in clinical practice, which needs further validation. Taylor & Francis 2023-01-17 /pmc/articles/PMC9848373/ /pubmed/36648027 http://dx.doi.org/10.1080/0886022X.2022.2161396 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Chen, Fei-Fei
Yu, Xiao-Juan
Wang, Hui
Zhang, Xu
Tan, Ying
Qu, Zhen
Wang, Su-Xia
Yu, Feng
Chen, Min
Zhao, Ming-Hui
Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
title Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
title_full Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
title_fullStr Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
title_full_unstemmed Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
title_short Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
title_sort clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848373/
https://www.ncbi.nlm.nih.gov/pubmed/36648027
http://dx.doi.org/10.1080/0886022X.2022.2161396
work_keys_str_mv AT chenfeifei clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT yuxiaojuan clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT wanghui clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT zhangxu clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT tanying clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT quzhen clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT wangsuxia clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT yufeng clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT chenmin clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy
AT zhaominghui clinicalvalueoftherenalpathologicscoringsystemincomplementmediatedthromboticmicroangiopathy